• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Modeling the functional genomics of autism using human neurons.

Human neural progenitors from a variety of sources present new opportunities to model aspects of human neuropsychiatric disease in vitro. Such in vitro models provide the advantages of a human genetic background combined with rapid and easy manipulation, making them highly useful adjuncts to animal models. Here, we examined whether a human neuronal culture system could be utilized to assess the transcriptional program involved in human neural differentiation and to model some of the molecular features of a neurodevelopmental disorder, such as autism. Primary normal human neuronal progenitors (NHNPs) were differentiated into a post-mitotic neuronal state through addition of specific growth factors and whole-genome gene expression was examined throughout a time course of neuronal differentiation. After 4 weeks of differentiation, a significant number of genes associated with autism spectrum disorders (ASDs) are either induced or repressed. This includes the ASD susceptibility gene neurexin 1, which showed a distinct pattern from neurexin 3 in vitro, and which we validated in vivo in fetal human brain. Using weighted gene co-expression network analysis, we visualized the network structure of transcriptional regulation, demonstrating via this unbiased analysis that a significant number of ASD candidate genes are coordinately regulated during the differentiation process. As NHNPs are genetically tractable and manipulable, they can be used to study both the effects of mutations in multiple ASD candidate genes on neuronal differentiation and gene expression in combination with the effects of potential therapeutic molecules. These data also provide a step towards better understanding of the signaling pathways disrupted in ASD.

Pubmed ID: 21647150


  • Konopka G
  • Wexler E
  • Rosen E
  • Mukamel Z
  • Osborn GE
  • Chen L
  • Lu D
  • Gao F
  • Gao K
  • Lowe JK
  • Geschwind DH


Molecular psychiatry

Publication Data

February 24, 2012

Associated Grants

  • Agency: NIMH NIH HHS, Id: K08 MH074362-05
  • Agency: NIMH NIH HHS, Id: K08MH074362
  • Agency: NIMH NIH HHS, Id: K99MH090238
  • Agency: NICHD NIH HHS, Id: N01-HD-4-3368
  • Agency: NICHD NIH HHS, Id: N01-HD-4-3383
  • Agency: NIMH NIH HHS, Id: R00 MH090238
  • Agency: NIMH NIH HHS, Id: R01 MH081754
  • Agency: NIMH NIH HHS, Id: R01MH081754
  • Agency: NIMH NIH HHS, Id: R37 MH060233
  • Agency: NIMH NIH HHS, Id: R37MH060233

Mesh Terms

  • Autistic Disorder
  • Cell Differentiation
  • Cells, Cultured
  • Fetus
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental
  • Genomics
  • Genotype
  • Gestational Age
  • Humans
  • Ki-67 Antigen
  • Models, Genetic
  • Nerve Tissue Proteins
  • Neural Stem Cells
  • Neurons
  • Oligonucleotide Array Sequence Analysis